Castle Biosciences Inc (NASDAQ: CSTL) kicked off on Friday, up 6.05% from the previous trading day, before settling in for the closing price of $35.72. Over the past 52 weeks, CSTL has traded in a range of $14.59-$36.60.
While this was happening, its average annual earnings per share was recorded -281.11%. With a float of $28.43 million, this company’s outstanding shares have now reached $29.16 million.
Castle Biosciences Inc (CSTL) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Castle Biosciences Inc is 2.60%, while institutional ownership is 91.27%. The most recent insider transaction that took place on Nov 18 ’25, was worth 91,106. In this transaction Pres. & Chief Exec. Officer of this company sold 2,678 shares at a rate of $34.02, taking the stock ownership to the 50,937 shares. Before that another transaction happened on Nov 11 ’25, when Company’s Chief Financial Officer sold 5,388 for $35.08, making the entire transaction worth $189,011. This insider now owns 43,328 shares in total.
Castle Biosciences Inc (CSTL) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported 0.32 earnings per share (EPS), higher than consensus estimate (set at 0.04) by 0.28. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.45 per share during the current fiscal year.
Castle Biosciences Inc (NASDAQ: CSTL) Trading Performance Indicators
Take a look at Castle Biosciences Inc’s (CSTL) current performance indicators. Last quarter, stock had a quick ratio of 6.31. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.22. Likewise, its price to free cash flow for the trailing twelve months is 34.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.45, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.42 in one year’s time.
Technical Analysis of Castle Biosciences Inc (CSTL)
Let’s dig in a bit further. During the last 5-days, its volume was 0.52 million. That was better than the volume of 0.46 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 81.71%.
During the past 100 days, Castle Biosciences Inc’s (CSTL) raw stochastic average was set at 98.85%, which indicates a significant increase from 97.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.88 in the past 14 days, which was higher than the 1.08 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $26.34, while its 200-day Moving Average is $21.56. However, in the short run, Castle Biosciences Inc’s stock first resistance to watch stands at $38.86. Second resistance stands at $39.84. The third major resistance level sits at $41.53. If the price goes on to break the first support level at $36.19, it is likely to go to the next support level at $34.50. The third support level lies at $33.52 if the price breaches the second support level.
Castle Biosciences Inc (NASDAQ: CSTL) Key Stats
The company with the Market Capitalisation of 1.11 billion has total of 29,189K Shares Outstanding. Its annual sales at the moment are 332,070 K in contrast with the sum of 18,250 K annual income. Company’s last quarter sales were recorded 83,040 K and last quarter income was -500 K.
